ON THE QUESTION OF THE START OF A STUDY ON THE DIAGNOSIS OF BONE MINERAL DENSITY IN THE POPULATION OF THE ABAY REGION
Introduction. Osteoporosis (OP) is a systemic skeletal disease characterized by a decrease in bone mass, leading to increased bone fragility and the risk of fractures. AP - is the most common chronic metabolic bone disease and is a major global health problem, resulting in 8.9 million fractures worldwide each year.
Purpose of the study. Study of risk factors for disruption of the process of bone mass accumulation and age-related features of skeletal mineralization, which is inextricably linked with the quantitative assessment of bone mass using X-ray densitometry.
Methods. The study aimed at identifying factors for the development of AP in adults and children in the city of Semey and the Abay region took place in several stages. Stage 1. Development of questionnaires. Stage 2. Testing of study groups. The survey was carried out manually on paper and then entered into electronic format in Excel. Stage 3. Osteodensitometry. At the University Hospital of Semey Medical University, the study groups underwent X-ray densitometry using the PRIMUS Osteosys device (2020).
Results. According to the results of a survey of 30 adults: the average age was 40±5 years, the average BMI was 24±2. According to the results of a survey of 30 children: the average age was 13±1 years, the average BMI was 20.2±1. When conducting dual-energy X-ray absorptiometry (DXA), AP was detected in 5 (17%) people, osteopenia in 9 (30%) people, which can be associated with the influence of social and everyday factors. Based on the survey data, it can be noted that children have low physical activity, which in turn affects the development of low BMD.
Conclusions. The authors propose to use the densitometry method, which identifies the most reliable risk factor for fractures – low bone mineral density. The densitometry method should be included in the list of studies if osteoporosis is suspected, and it is preferable to use x-ray densitometers.
Madina R. Madiyeva1, https://orcid.org/0000-0001-6431-9713
Alida Sh. Kaskabaeva1, https://orcid.org/0000-0002-5184-214X
Tamara Kh. Rymbaeva1, https://orcid.org/0000-0003-3769-6796
Aliya R. Alimbaeva1, https://orcid.org/0000-0002-5082-4636
Gulzhan B. Bersimbekova1, https://orcid.org/0000-0002-9416-5054
Gulnur B. Kanapiyanova1, https://orcid.org/0000-0002-8102-5220
Dinara O. Akhmetzhanova1, https://orcid.org/0000-0003-0000-2535
1 NСJSC «Semey Medical University», Semey, Republic of Kazakhstan.
1. Габдулина Г.Х., Исаева Б.Г., Исаева С.М., Лесняк О.М. Результаты аудита состояния проблемы остеопороза в Республике Казахстан // Остеопороз и остеопатии. 2020. 23(1):69-70.
2. Исаева С.М., Исаева Б.Г., Лесняк О.М. Заболеваемость остеопорозом населения Казахстана и выявление инцидентности остеопоротических переломов в г. Талдыкорган // Вестник Каз НМУ. 2018. 4:249-253.
3. Клинический протокол диагностики и лечения. Остеопороз. (2016) Протокол № 12.
4. Киселева Н.Г., Таранушенко Т.Е., Голубенко Н.К. Диагностика остеопороза в детском возрасте // Медицинский Совет. 2020. (1):186-193.
5. Boyce A.M., Gafni R.I. Approach to the child with fractures // J Clin Endocrinol Metab. 2011. 96(7):1943–1952.
6. Catherine M. Gordon, Mary B. Leonard, Babette S. Zemel. 2013 Pediatric Position Development Conference: executive summary and reflections. Practice Guideline // J Clin Densitom. 2014. 17(2):219-24. doi:10.1016/j.jocd.2014.01.007.
7. Disser N.P., De Micheli A.J. et al. Musculoskeletal consequences of COVID-19 // J Bone Joint Surg Am. 2020. 102:1197–204. 10.2106/JBJS.20.00847
8. Gordon C.M., Leonard M.B., Zemel B.S. International Society for Clinical Densitometry. 2013 Pediatric Position Development Conference: executive summary and reflections // J Clin Densitom. 2014. 17(2):219–224.
9. Johnell O., Kanis J.A. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures // Osteoporos Int. 2006. 17:1726–1733.
10. Kanis J.A., Bianchi G., Bilezikian J.P., Kaufman J.M., Khosla S., Orwoll E., Seeman E. Towards a diagnostic and therapeutic consensus in male osteoporosis // Osteoporos Int. 2011. 22:2789–2798.
11. Sidlauskas K.M., Sutton E.E., Biddle M.A. Osteoporosis in men: epidemiology and treatment with denosumab // Clinical Interventions in Aging. 2014.9.593–601.
12. Thambiah S.C., Yeap S.S. Osteoporosis in South-East Asian countries // Clinical Biochemist: Reviews. 2020. 41. 29–40. (10.33176/AACB-19-00034)
13. The North American Menopause Society. Management of osteoporosis in postmenopausal women: The 2021 position statement of The North American MenopauseSociety. Menopause. 2021. 28:973–97. 10.1097/GME.0000000000001831
14. Weaver C.M. Parallels Between Nutrition and Physical Activity: Research Questions in Development of Peak Bone Mass. Research Quarterly for Exercise and Sport, 2015; 86 (2:103–106. doi:10.1080/02701367.2015.1030810
15. Weaver C.M., Gordon C.M. et al. The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations // Osteoporos Int 27, 1281–1386 (2016). https://doi.org/10.1007/s00198-015-3440-3.
16. Wren T.A., Liu X., Pitukcheewanont P., Gilsanz V. Bone acquisition in healthy children and adolescents: comparisons of dual-energy x-ray absorptiometry and computed tomography measures // J Clin Endocrinol Metab 2005. 90:1925–1928.
References [1-4]:
1. Gabdulina G.Kh., Isayeva B.G., Isayeva S.M., Lesnyak O.M. Rezul'taty audita sostoyaniya problemy osteoporoza v Respublike Kazakhstan [Results of an audit of the state of the problem of osteoporosis in the Republic of Kazakhstan]. Osteoporoz i osteopatii [Osteoporosis and Osteopathy]. 2020. 23(1):69-70. [in Russian]
2. Isayeva S.M., Isayeva B.G., Lesnyak O.M. Zabolevayemost' osteoporozom naseleniya Kazakhstana i vyyavleniye intsidentnosti osteoporoticheskikh perelomov v g. Taldykorgan Kazakhstan [Incidence of osteoporosis in the population of Kazakhstan and identification of the incidence of osteoporotic fractures in the city of Taldykorgan]. Vestnik Kaz NMU [Bulletin of KazNMU]. 2018;4:249-253. [in Russian]
3. Klinicheskiy protokol diagnostiki i lecheniya. Osteoporoz. (2016) Рrotokol №12 [Kazakhstan Clinical protocol for diagnosis and treatment. Osteoporosis. (2016) Protocol No. 12].
4. Kiseleva N.G., Taranushenko T.Ye., Golubenko N.K. Diagnostika osteoporoza v detskom vozraste. Meditsinskiy Sovet. Kazakhstan [Diagnosis of osteoporosis in childhood]. Meditsinskii Sovet [Medical Council.]. 2020. (1):186-193. [in Russian]
Number of Views: 53
Category of articles:
Original articles
Bibliography link
Madiyeva M.R., Kaskabaeva A.Sh., Rymbaeva T.Kh., Alimbaeva A.R., Bersimbekova G.B., Kanapiyanova G.B., Akhmetzhanova D.O. On the question of the start of a study on the diagnosis of bone mineral density in the population of the Abay region // Наука и Здравоохранение. 2023. 5(Т.25). С. 121-127 DOI 10.34689/SH.2023.25.5.016Related publications:
ANALYSIS OF CLINICAL AND DEMOGRAPHIC INDICATORS OF PATIENTS WITH PARKINSON'S DISEASE IN THE SOUTHERN REGION OF KAZAKHSTAN
A COMPARATIVE STUDY OF DRUG POLICY REGARDING ORPHAN DISEASES IN THE USA, THE EUROPEAN UNION, AND THE REPUBLIC OF KAZAKHSTAN
MUTATIONS IN CARDIAC ION CHANNEL GENES IN KAZAKHSTANI PATIENTS WITH LONG QT SYNDROME
GENETIC FEATURES OF CONGENITAL DYSFUNCTION OF THE ADRENAL CORTEX CAUSED BY 21-HYDROXYLASE DEFICIENCY IN PERSONS OF KAZAKH NATIONALITY
NON-MOTOR SYMPTOMS IN PARKINSON'S DISEASE USING THE EXAMPLE OF AKTOBE PATIENTS